Researchers: after your last paper was published, what did you do to get it in front of anyone beyond the journal's readership? If the answer is "not much", I'd love 15 minutes of your time. Building a tool to help. Need honest input first. DM me.

One pill can kill. Fentanyl is 100x stronger than morphine, per CDC data. Kids don't know what's in what they take. In the ED, I see families blindsided. Naloxone in your home isn't giving up. It's the same logic as a seatbelt. Most parents just didn't know in time.

Dental visits jump after starting medications for opioid use disorder (MOUD)—across methadone, buprenorphine, and naltrexone. Likely reflects increased health-seeking, not drug harm. Studies on dental risks should account for this behavior shift. journals.lww.com/journaladdic...

Dads, your presence at pediatric visits matters more than you think. Kids notice when their father shows up. That alone builds trust. And trust is what makes them tell you the hard stuff later, before it becomes a crisis.

Urgent care handles most fevers, ear infections, and minor cuts faster and cheaper than the ED. Save the ER for breathing trouble, seizures, severe pain, or anything that feels truly wrong. Your gut matters. The ED will always be there when you really need it.

As a harm reduction researcher, I've seen that encampment sweeps don’t fix homelessness. They disrupt care, fracture trust, and make it harder to get care. Residents are asking for low-barrier safe sleep sites, storage, and dignity. That’s not radical. It's public health. archive.ph/ewTbD

New work on managing opioid use disorder in the ED. Buprenorphine and methadone save lives. We need clinicians using these tools confidently. This piece breaks down the evidence and practical approach. Read the full article

Among adults presenting to the emergency department with untreated #opioid use disorder, ED-initiated 7-day extended-release injectable #buprenorphine and sublingual buprenorphine resulted in similar rates of treatment engagement at 7 days. ja.ma/4bqdbnC

💬 Editorial: ED-initiated extended-release injectable and sublingual #Buprenorphine show similar short-term engagement and low precipitated withdrawal rates, but further data on safety and adherence are needed. ja.ma/4beZBVk

If you ever considered seeking addiction treatment, watch this. Dr. Noelle Martinez from the @sfpublichealth.bsky.social on-demand buprenorphine telehealth line summarizes easy to access treatment options available to San Franciscans. Start your recovery journey today by calling 888-246-3333.

Good research sitting in a journal changes nothing. Implementation is the actual work. Policy moves through relationships, timing, and political will. Funders want scalability. Dissemination isn't a box to check at the end. It's the whole point. Science unused is science wasted.

Weekly extended-release buprenorphine for #OpioidUseDisorder in #pregnancy resulted in higher abstinence rates than sublingual buprenorphine, with similar maternal and neonatal safety outcomes. ja.ma/3NmbT5e

Opioid use disorder is a chronic disease characterized by a maladaptive pattern of opioid use despite negative consequences. 📌 This JAMA Clinical Guidelines Synopsis summarizes the 2024 CRISM guideline on management of opioid use disorder. ja.ma/3Pcqhxy

Medications can decrease risk of withdrawal, overdose, and death in people with opioid use disorder. 📄 This JAMA Patient Page describes medications used to treat opioid use disorder, opioid withdrawal, and opioid overdose. ja.ma/4luJg2c

A p-value under 0.05 doesn't mean a treatment works. It means the result is unlikely by chance. Big difference. Most evidence never reaches patients. That gap is where implementation science lives. Knowing what works is step one. Getting it done is the whole game.

Weekly extended-release buprenorphine during pregnancy results in higher rates of opioid abstinence and fewer serious adverse events compared to daily sublingual buprenorphine. doi.org/hbsrh5

One fentanyl pill can kill. Kids don't know what's in what they're taking. Per CDC, it's now the leading cause of teen death. The ED shows me what prevention missed. Harm reduction isn't giving up. It's keeping kids alive long enough to make better choices.

Virginia - ‘Save as many lives as possible’: Recovery advocate praises Richmond’s expansion of harm reduction vending machine program www.wric.com/news/local-n...

Stigma kills. It stops people from seeking care and shapes how clinicians treat patients. My new piece on substance use disorders in emergency medicine digs into what we know, what we miss, and what needs to change. Worth a read if you work with or love someone affected. Read the full piece

Youths starting #BuprenorphineNaloxone for opioid use disorder had a lower risk of opioid overdose during active treatment vs methadone, but experienced shorter treatment duration. ja.ma/419BiSE

Dads, your presence matters more than your perfect words. Research shows kids with engaged fathers are less likely to use drugs. You don't need a script. Just show up, stay curious about their world, and keep the door open. That consistency is the protection.

Good research doesn't change practice on its own. It needs champions, timing, and systems ready to absorb it. Implementation is the gap between knowing and doing. That gap costs lives. Closing it is its own science, and most researchers never learn it.

With tens of millions still unspent, Massachusetts is soliciting public input on how to use money meant to mitigate damage wrought by the opioid epidemic binj.news/2026/03/11...

With tens of millions still unspent, Massachusetts is soliciting public input on how to use money meant to mitigate damage wrought by the opioid epidemic binj.news/2026/03/11...

Youths starting #BuprenorphineNaloxone for opioid use disorder had a lower risk of opioid overdose during active treatment vs methadone, but experienced shorter treatment duration. ja.ma/4rxOewB

Dads: your kid's pediatrician wants you in the room. Not just dropping off. Asking questions, knowing the meds, knowing the friends. Research is clear that involved fathers change outcomes. Your presence is a clinical intervention.

New on-demand session for clinicians: substance use treatment in pregnancy, postpartum, and newborns. Part of the ASAM 2025 Review Course. 30 minutes. Practical, evidence-based. Worth your time. Watch the session

Under state law, several effective tools to treat the opioid epidemic are tightly constrained. During this year’s legislative session, lawmakers largely left these restrictions in place. mountainstatespotlight.org/2026/03/09/o...

Overdose deaths dropped ~19% in 2025 after a 27% drop in 2024 — real progress, but ~72,000 deaths/year is still a crisis, not a new normal. Sustained investment in treatment access and harm reduction is what drives these trends. We can't afford to plateau. Read the full analysis

Have you registered for next week’s #PRF #journalclub with @iasp.bsky.social Acute Pain SIG and Dan Arendt? Join us on 18 March to discuss Harvey et al’s review on buprenorphine and full agonist opioids for acute postoperative pain management bit.ly/3ZKd6pp

Fever alone rarely means ER. Most kids with high temps do fine at urgent care. Save the ED for trouble breathing, uncontrolled bleeding, seizures, or a gut feeling something is seriously wrong. Parents know their kids. That instinct matters more than any number on a thermometer.

Most teens who die from opioids now didn't know they took fentanyl. Per CDC data, it's in counterfeit pills that look exactly like Adderall or Xanax. One pill can be lethal. That's not a scare tactic — it's what we see in the ED. What questions do you have that feel too scary to ask?

#TWiNPP Mattey-Mora et al. show that integrated neurobiological and environmental models better predict adolescent risk for substance use disorders in a longitudinal study 🧠 / @joeyaloimdphd.bsky.social www.nature.com/articles/s41...

Here is the latest LA Public Health dept. report on deaths among people who are unhoused showing a dip in their "mortality rate" for the first time since 2014: publichealth.lacounty.gov/chie/reports... Among the recommendations, which include housing, they also call for harm reduction strategies.

New research on peer-led substance use prevention in schools — and it's promising. When students lead the conversation, other students actually listen. Sharing our mixed-methods evaluation of a school-based program that's worth knowing about. Read the full study

New research from our team: teens who use substances before a trauma have worse outcomes in the ED. This matters for how we screen, treat, and support adolescents after injury. Worth a read if you care about young people's health. Read the full study

Teens with opioid use disorder show up in the ER. Do we have a plan for them? I've been working on building one. New abstract out now on creating a protocol specifically for adolescents in the ED. Read the abstract

New in Nature Medicine: ChatGPT Health under-triaged 52% of true emergencies in a structured stress test. The crisis guardrail for suicidal ideation fired MORE reliably when patients hadn't identified a method than when they had. doi.org/10.1038/s415...

New NEJM data: illicit fentanyl exposures in kids under 6 have risen sharply over 11 years. Even tiny amounts can cause fatal respiratory depression in young children. This is a pediatric emergency trend we can't ignore. Read the full study

Dads: the single biggest protective factor against teen drug use isn't rules or random drug tests. It's connection. Per SAMHSA research, teens who feel close to a parent are significantly less likely to use substances. What does that connection look like in your house?

New paper: 548 teens + 544 caregivers on ED substance use screening. 50% supported it. Top barrier: they don't trust what happens to the information. But teens who KNEW they were being screened? Comfort nearly doubled. doi.org/10.1016/j.acepjo.2025.100198

Adolescent overdose deaths doubled in just 2 years. CDC data show monthly deaths among ages 10–19 rose 109% from mid-2019 to mid-2021, driven largely by illicitly manufactured fentanyl contaminating the drug supply. Every number is a child. Read the full CDC report

Milwaukee - Black Balloon Day 2026: Honoring lives lost and launching the midwest Regional Black and Brown Harm Reduction Alliance milwaukeenns.org/2026/03/04/p...

Fentanyl killed 5,194 kids between 1999–2021 — 37.5% of all pediatric opioid deaths, mostly teens. The sharpest rise hit after 2016 as illicit fentanyl flooded the supply. This is the clearest picture yet of how this crisis landed on our youngest patients. Full study in JAMA Pediatrics

"As implementation researchers probe more deeply into hidden causal mechanisms...explanatory work shifts the focus from description to causation" Paper: "Potential Applications of Realist Methodologies to Implementation Science Research" journals.sagepub.com/doi/10.1177/...

Myth: the ER is for "real" emergencies only. Truth: if you're genuinely unsure whether your child is seriously ill, that uncertainty IS the reason to come in. We'd rather see 10 kids who didn't need us than miss the one who did. What's kept you from coming in when you were worried?

Yoga as an adjunct to standard buprenorphine therapy for #OpioidUseDisorder accelerated withdrawal stabilization, improved heart rate variability, and reduced anxiety, sleep latency, and pain compared with standard care alone. ja.ma/4spiJ8O

Drug overdose deaths dropped 26% from 2023 to 2024 — the largest single-year decline on record, per new CDC data. Sustained decreases like this are rare and meaningful, though overdose mortality remains far above pre-fentanyl levels. Cautious optimism is warranted. Full CDC data brief here

New study co-authored by CP3’s Dr. Katie Suda & Yilei Liu found that 1 in 10 pediatric dental visits involving opioids led to overdose or persistent use—highest in young children. Highlights need for caution and nonopioid pain management. pubmed.ncbi.nlm.nih.gov/41081662/

1 in 10 children who received #opioids during a dental visit experienced an overdose or persistent #OpioidUse. The message is clear: guideline-based nonopioid pain management is essential in pediatric dental care. Read more from @Sudamonas & colleagues: pubmed.ncbi.nlm.nih.gov/41081662/